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EXPRESSION OF TISSUE-TYPE TRANSGLUTAMINASE CORRELATES 
POSITIVELY WITH METASTATIC PROPERTIES OF HUMAN MELANOMA 
CELL LINES 
Jan J.M. VAN GRONINGEN, Steve L. KLINK, Henri P.J. BLOEMERS and Guido W.M. SWART’ 
Department of Biochemistry, Utrivcvsity of Nijmegen, Nqmegen, The Netherlands. 
In this study the relationship between tissue-type transgluta- 
minase (TGase2) activity and the propensity to metastasize was 
investigated in human melanoma cell lines with different meta- 
static behavior. TGase2 catalyzes an acyl-transfer reaction 
between peptide-bound glutamine residues and primary amines, 
including the r-amino group of lysine residues. Northern-blot 
analysis demonstrated that TGase2 RNA-expression (3.7 kb) 
was elevated in highly metastatic cell lines (MV3 and BLM) as 
compared to weakly metastatic ones (I F6 and 530). Immunopre- 
cipitation and enzyme assays of TGaseZ showed that the 
differential expression at the mRNA level was also reflected at 
the protein level. These findings reveal a positive relation 
between the expression of TGase2 and the metastatic proper- 
ties of the human melanoma cell lines. 
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Modifications of proteins commonly serve special purposes, 
e.g. they can modulate the activity of signal transduction 
cascades, determine protein fate, and stabilize intra- and 
extracellular matrices. Calcium-dependent acyl transferases, 
also known as transglutaminascs (TGases), form one group of 
enzymes involved in these processes. TGases (EC 2.3.2.13) 
catalyse an acyl transfer reaction between peptide-bound 
glutamine residues and primary amine groups. As a result, 
substrate proteins incorporate amines (such as polyamines), or 
are cross-linked via E(y-glutamy1)lysine bridges if the amine is 
a peptide-bound lysine (Folk and Finlayson, 1977). 
In mammals, 5 distinct TGases have been described. TGase1 
is a particulate or membrane-associated activity of about 90 
kDa, originally discovered in epidermal keratinocytes 
(Thacher and Rice, 1985) and now known to be widely 
expressed (Kim et al., 1992); TGase2 is a ubiquitous soluble or 
tissue-type activity of about 80 kDa, which is widely distributed 
in human cells and tissues (Gentile el al., 1991); TGase3, 
known as the epidermal or hair follicle TGase, is a soluble 
pro-cnzymc activity of about 77 kDa (Kim et al., 1991); 
furthermore, an inactive TGase-like protein of about 75 kDa 
exists, which is a ubiquitous constituent of the plasma mem- 
brane of most eukaryotic cells (Sung et al., 1990), and the 
77-kDa catalytic subunit of blood-clotting factor XI11 also has 
TGasc activity (Ichinose et al,, 1986). TGase2, by far the most 
abundant of these enzymes, has been implicated in the 
activation of  receptor-mediated endocytosis (Davies et al., 
1980). hormone secretion (Bungay et al., 1986), cell adhesion 
by cross-linking of extracellular proteins (Gentile et al., 1992; 
Martinez et al., 1989), and the formation of the apoptic 
envelope in cells undergoing programmed cell death (Fesus et 
al., 1987; Alaoui et al., 1992). 
The present study was undertaken to examine the TGase2 
activity in human melanoma cell lines with differing metastatic 
potential. Whereas reports on mouse melanoma cell lines 
(Beninati et al., 1993), hamster fibrosarcoma (Knight et al., 
1990), and rat hepatocellular carcinoma (Hand et al., 1988) 
suggested that decreased lcvcls of TGase2 activity are associ- 
ated with increased metastatic potential, our investigations on 
human mclanoma cell lines show that TGase2 expression 
correlates positively with the gain of metastatic properties. 
MATERIAL AND METHODS 
Material 
All radiolabeled chemicals and Hybond N-plus membranes 
were from Amersham (Den Bosch, The Netherlands). Kodak 
X-Omat AR5 films (Rochester, NY) were used for autoradiog- 
raphy. Purified guinea-pig tissue TGase was supplied by Sigma 
(Brussels, Belgium). Cell culture media and FCS were ob- 
tained from GIBCO (Grand Island, NY). All other reagents 
were of analytical grade. 
Melanoma cell lines and xenograjs 
Human melanoma cell lines MV3, BLM, 530 and 1F6 (van 
Muijen et al., 1991a, b )  were grown as monolayers on Dulbec- 
co’s modified Eagle’s medium supplemented with 10% FCS, 
glutamine (2 mM), penicillin G (100 units/ml), streptomycin 
(100 pg/ml) and pyruvate (1 mM). Cells were harvested by 
trypsinization. Xenograft tumors from nude mice were ob- 
tained as described (van Muijen et al., 1991a, b) .  Within the 
panel of human melanoma cell lines, 1F6 and 530 represent 
the non-metastatic or weakly metastatic cell lines, with a 
metastasis frequency of less than 10%. The highly metastatic 
cell lines BLM and MV3 disseminate with a frequency of 50 
and YO%, respectively. 
RNA isolation and Northem-blot analysis 
Total RNA was isolated using the lithium-urea procedure 
described by Auffray and Rougeon (1980). Between 10 and 20 
pg of total RNA were glyoxylated (McMaster and Carmichael, 
1977), size-fractionated on 1% agarose gels and blotted to 
Hybond N+ membranes (Amersham, Aylesbury, UK). Hybrid- 
izations were performed according to Church and Gilbert 
(1984); the RNA was hybridized overnight in 0.5 M Na2HP04, 
pH 7.2, 1% BSA, 7% SDS, 1 mM EDTA and 0.1 mg/ml 
denatured herring sperm DNA at 65°C with 32P-labeled DNA 
probes to a maximum of 1 x lo6 cpmiml. Filters were washed 
at 65°C in 0.1 M Na2HP04, p H  7.2,0.5% SDS, 1 mM EDTA. 
DNA probes 
The human TGase2 cDNA, a 3.5-kb EcoRl fragment, was a 
generous gift from Dr. P. Davies, Houston, TX (Gentile et al., 
1991). A 28s ribosomal probe was used to reconfirm equal 
loading of RNA samples in each lane. Probes were radiola- 
beled by nick-translation. 
Cytoplasmic extract preparation 
Cells were resuspended in 5 ml lysis buffer (10 mM Tris- 
HCI, p H  8.0, 1.5 mM MgCI2, 0.5 mM dithiothreitol, 0.1 mM 
EDTA, 1 mM phenylmethylsulfonyl fluoride, 1% trasylol) and 
lysed by 7 strokes in a Dounce homogenizer. Nuclei were 
removed by centrifugation at  1,000 g for 15 min. Supernatant 
was concentrated by 75% (NH4)2S04-precipitation followed 
by centrifugation at 150,OOOg for 20 min. The pellet containing 
‘To whom correspondence and reprint requests should be sent, at 
the Dept. of Biochemistry, Science Faculty, University of Nijmegen, 
P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Fax: 0031 80 
540525. 
Received: June 29, 1994 and in revised form October 8,1994. 
384 VAN GRONINCEN ETAL.  
the TGase2 protein was resuspended in, and dialyzed against, 
50 mM Tris-HCI, p H  8.0, 100 mM NaCI. The protein concen- 
tration was determined by the Coomassie brilliant blue binding 
method (Bradford, 1976). 
En,yme ossays 
The enzymatic incorporation of [13C]methylamine into en- 
dogenous substrate was used to assay TGase activity (Lorand 
et al.. 1981). The incubation mixture contained 50 mM Tris- 
HCI, pH 8.0, 100 mM NaCI, 10 mM CaCI?, 10 mM dithio- 
threitol, 0.4 mM [‘TC]methylamine with specific activity 56 
mCiimmol and 0.3 mg cytoplasmic protein extract in a final 
volume of 50 PI. After 60 min incubation at 37”C, 10-pI 
aliquots of the incubation mixture were spotted onto Whatman 
3MM filter paper. Free [“Tlmethylamine was eliminated by 
washing with excess of ice-cold 5 %  TCA. Filters were dried 
and counted after addition of 5 ml Aqualuma Plus (LUMAC 
LSC, Groningen, The Netherlands) in a Beckman model 2800 
liquid scintillation counter. 
For identification of  the TGase substrate(s), 5 PI (30 Kg) of 
the incubation mixture were analyzed on 12.5% SDS- 
polyacrylamide gel. The gel was fluorographed, dried and 
exposed. 
Cell labelling rind inimunoprecipitntion 
Cell labelling and isolation of proteins were based on the 
method described by Banks-Schlegel and Harris (1983). For 
labelling, the cells were plated in dishes 10 cm in diameter and 
grown until 50% confluent. Cells were washcd twice with PBS 
and incubated for 30 min with 4 ml of methionine-free Eagle’s 
minimal essential medium, to which were added 40 pCi 
(3sS]methionine (>  1000 Ciimmol) and dialyzed FCS at a final 
concentration of 6%. After overnight incubation at 37”C, the 
cells were washed 3 times with PBS. The labelled cell pellet 
was lysed in 75 PI of lysis buffer (20 mM Tris-HCI, pH 7.7, 1 
mM phenylmethylsulfonyl fluoride, 2% SDS, 10 mM dithio- 
threitol). The lysates were boiled and centrifuged to eliminate 
insoluble materials. The supernatant was diluted in 1.425 ml of 
RIPA buffer without SDS (RIPA buffer: SO mM Tris-HCI, pH 
7.5, 0.15 M NaCI, 1% Triton X-100, 1% sodium deoxycholate, 
0.1% SDS, 0.5% Trasylol), and centrifuged. The resulting 
supernatant was used for immunoprecipitation. Aliquots con- 
taining 2.5 x loh cpm of [’sSS]methionine-labeled cell extracts 
were used for each precipitation. Affinity-purified, rabbit 
anti-human TGasc2 IgG-type antibodies (Dr. L. Fesus, Debre- 
cen Medical School Apoptosis Research Foundation, Hun- 
gary) were used in the immunoprecipitations. After 3 washes 
with RIPA buffer, the immunoprecipitates were analyzed on a 
10% SDS-polyacrylamide gel. The gel was fluorographed, 
dried and exposed. 
RESULTS 
Presence of TGase2 transcripts in human melanoma cell lines 
Total RNA isolated from different human melanoma cell 
lines was subjected to Northern-blot analysis with a 3.5-kb 
human Tgdse2 cDNA probe. Autoradiography revealed the 
cognate, 3.7-kb hybridization signal (Fig. 1).  Pronounced 
Tgase2 expression was seen in the highly metastatic cell lines 
BLM and MV3 (lanes C, D), while for the weakly metastatic 
cell lines. only trace expression was detectable in 1F6 (lane B), 
and no expression in 530 (lane A). To determine whether a 
corresponding expression pattern would occur in the xenograft 
tumors of these cell lines, we analyzed total RNA from 
xenografts (Fig. 2). The observed Tgase2 expression was 
highest in the BLM- and MV3-derived xenografts (lanes C, D), 
while no exprcssion was detected in the 530- and 1F6-derived 
xenografts (lanes A, B). 
FIGURE 1 - Northern-blot analysis of human melanoma cell 
lines; 10 pg of total RNA were loaded in each lane. Lane A, 530; 
lane B, 1F6; lane C, BLM; lane D, MV3. The blot was hybridized 
to radiolabeled 3.5-kb human TGase2 cDNA. The MW marker 
was h DNA digested with restriction enzyme Hindl l l .  Below: 
control hybridization, using a 28s ribosomal probe. 
FIGURE 2 - Northern-blot analysis of melanoma xenografts in  
nude mice; 20 pg of total RNA were loaded in each lane. Lane A, 
530; lane B, 1F6: lane C, BLM; lane D, MV3. The blot was 
hybridized to radiolabeled 3.5-kb human TGase2 cDNA. The MW 
marker was A DNA digested with Hindl l l .  Below: control 
hybridization. using a 28s ribosomal probe. 
TGase enzymatic activity in hiiman melanoma cell lines 
For further characterization of the TGase2 expression, the 
enzymatic activity was measured in cytoplasmic extracts pre- 
pared from the human melanoma cell lines with differing 





BLM MV3 I F 6  530 blank 
FIGURE 3 - Levels of TGase activity in the human melanoma cell 
lines BLM, MV?, IF6 and 530. TGase activity was determined on 
the cell extracts as described in the text. The blank activity 
represents assays with BLM and MV3 extracts in the presence of 
50 m M  EDTA. Data represent the mean values * SE from 3 
experiments. 
metastatic behavior. The assay tested endogenous TGase 
activity acting on endogenous substrates. As shown in Figure 3, 
the TGasc activity in the highly metastatic cell lines MV3 and 
BLM was significantly higher ( p  I 0.05 using a 2-sample 
f-test) than in the weakly metastatic cell lines 1F6 and 530, of 
which only thc former showed a low level of TGase activity. 
This result is in agreement with the differential expression of 
TGase2 transcripts shown in Figure 1. Some control assays 
wcrc pcrforrned in which purified guinea-pig TGase and/or 
cascine, a common TGase substrate, were included in the 
reaction mixtures (results not shown). These control assays 
make it  clear that the observed TGase activity profile is likely 
to reflect the corresponding differential mRNA expression 
pattern and cannot be explained by significant differences in 
the amounts of substrate proteins or specific enzyme inhibi- 
tors. 
For ii preliminary identification of the TGase substrates in 
the human melanoma cell lines, ['4C]methylamine ineorpora- 
tion into proteins of thc cytoplasmic extracts was analyzed on a 
12.5% SDS-polyacrylamide gel (Fig. 4). As expected from the 
enzyme assays. substratc-incorporated [ 14C]methylamine could 
be detected only in BLM and MV3 extracts (lanes A and C, 
respectively). As a consequence of its calcium dependence 
(Greenberg et d., 1991), the TGase activity was completely 
inhibited in the BLM and MV3 extracts in the presence of 10 
rnM EDTA (lanes B, D). The autoradiogram shows preferen- 
tial labelling of some selected substrates with a few typical 
differences between BLM and MV3. 
Ininiurio~~recrpiiati~n of TGusc2 
To examine TGase2 protein expression in the human 
melanoma cell lines, we performed irnmunoprecipitations o n  
(35Sjmcthionine-labeled cell extracts with anti-human tissue 
TGase2 antibodies. The immunoprecipitates obtained from 
the highly metastatic cell lines MV3 (lane B) and BLM (lane 
D). contain the expected 80-kDa TGase2 protein (Fig. 5). 
Tracc amounts of TGase2 are detectable in the weakly 
FIGURE 4 - Identification of TGase substrate(s) in several hu- 
man melanoma cell lines; 30 pg extract was loaded on each lane of 
a 12.5% SDS-polyacrylamide gel after [Wjmethylamine incorpo- 
ration as described in the text. Panel (0) shows the Coornassie 
brilliant blue staining pattern and (b) the corresponding autoradio- 
graph. Lanes A and B, BLM; lanes C and D, MV3: lane E, 1F6; 
lane F, 530. Lanes B and D, [14CJmethylamine incorporation assay 
in the presence of 50 mM EDTA. 
FIGURE 5 - Immunoprecipitation of TGase from several human 
melanoma cell lines; 2.5 x 10" cpm of ["Slmethionine-labeled cell 
extracts were used for each precipitation, and the immunoprecipi- 
tates were analyzed on a 10% SDS-acrylamide gel. Lanes A and B, 
MV3; lanes C and D, BLM; lanes E and F, 530; lanes G and H, 
1F6. Lanes A, C, E, and G were only incubated with protein 
A-Sepharose without addition of the antibody. The arrowhead 
indicates the position of human TGase2. 
metastatic cell line IF6 (lane H), while expression is absent in 
the 530 cell line (lane F). TGase2 was specifically precipitated 
by the affinity-purified anti-human tissue TGase2 rabbit IgG 
antibody, since the 80-kDa band is absent from control 
precipitations, in which only protein A-Sepharose was used 
with exclusion of the antibody (lanes A, C,  E, G). In summary, 
all applied assays (Northern-blot analysis, enzyme activity 
tests, irnmunoprecipitations) yield corresponding results and 
support the conclusion that TGase2 expression is elevated in 
metastasizing human melanoma cell lines. 
DISCUSSION 
Tissue-typc transglutaminase (TGase2) is a ubiquitous en- 
zyme, mainly because of its constitutive expression in smooth 
muscle and endothelium of the vessel wall, while it is inducible 
in most other cell types (Thomazy and Fesus, 1989). The 
enzymatic function of TGase2 is well characterized and, 
among its biological functions, a participation in endocytosis 
(Davies et a!., 1980), cellular adhesion (Gentile ei a!., 1992; 
Martinez et al., 1989) and apoptosis ( F e w  el ab, 1987; Alaoui 
et al., 1992) has been suggested. Additional experimental data 
are still required to characterize the suggested biological roles 
in detail. 
Our results, as reported here, reveal a positive correlation 
between TGase2 expression and metastatic behavior of human 
melanoma cell lines. We detected elevated expression of 
TGase mRNA only in the highly metastatic human melanoma 
cell lines MV3 and BLM. The differential expression of 
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